Development and Validation of a Nomogram for Predicting the Long-Term Survival in Patients With Chronic Thromboembolic Pulmonary Hypertension

被引:3
|
作者
Hu, Song [1 ]
Tan, Jiang-Shan [1 ]
Liu, Sheng [2 ]
Guo, Ting-Ting [1 ]
Song, Wu [2 ]
Peng, Fu-Hua [1 ]
Wu, Yan [1 ]
Gao, Xin [1 ]
Hua, Lu [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Thrombosis Ctr,Natl Ctr Cardiovasc Dis,State Key, Natl Clin Res Ctr Cardiovasc Dis,Key Lab Pulm Vas, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Adult Cardiac Surg Ctr, Natl Ctr Cardiovasc Dis,Dept Cardiac Surg, Beijing, Peoples R China
来源
关键词
ARTERIAL-HYPERTENSION; RISK STRATIFICATION; MANAGEMENT; HYPOXIA;
D O I
10.1016/j.amjcard.2021.09.045
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There remains a lack of prognosis models for patients with chronic thromboembolic pulmonary hypertension (CTEPH). This study aims to develop a nomogram predicting 3-, 5-, and 7-year survival in patients with CTEPH and verify the prognostic model. Patients with CTEPH diagnosed in Fuwai Hospital were enrolled consecutively between May 2013 and May 2019. Among them, 70% were randomly split into a training set and the other 30% as a validation set for external validation. Cox proportional hazards model was used to identify the potential survival-related factors which were candidate variables for the establishment of nomogram and the final model was internally validated by the bootstrap method. A total of 350 patients were included in the final analysis and the median followup period of the whole cohort was 51.2 months. Multivariate analysis of Cox proportional hazards regression showed body mass index, mean right atrial pressure, N-terminal probrain natriuretic peptide (per 500 ng/ml increase in concentration), presence of anemia, and main treatment choice were the independent risk factors of mortality. The nomogram demonstrated good discrimination with the corrected C-index of 0.82 in the training set, and the C-index of 0.80 (95% CI: 0.70 to 0.91) in the external validation set. The calibration plots also showed a good agreement between predicted and actual survival in both training and validation sets. In conclusion, we developed an easy-to-use nomogram with good apparent performance using 5 readily available variables, which may help physicians to identify CTEPH patients at high risk for poor prognosis and implement medical interventions. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:109 / 116
页数:8
相关论文
共 50 条
  • [1] DEVELOPMENT AND VALIDATION OF A NOMOGRAM FOR PREDICTING THE LONG-TERM SURVIVAL IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
    Hu, S.
    Tan, J.
    Liu, S.
    Hua, L.
    CHEST, 2022, 161 (06) : 451A - 451A
  • [2] Development and validation of a nomogram for predicting hemodynamic response to balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension
    Xin, Li
    Zhang, Yi
    Luo, Qin
    Zhao, Qing
    Yang, Tao
    Zeng, Qixian
    Jin, Qi
    Duan, Anqi
    Huang, Zhihua
    Hu, Meixi
    Zhang, Sicheng
    Gao, Luyang
    Xiong, Changming
    Zhao, Zhihui
    Liu, Zhihong
    RESPIRATORY MEDICINE, 2023, 220
  • [3] Characteristics and long-term survival of patients with chronic thromboembolic pulmonary hypertension in China
    Deng, Limin
    Quan, Ruilin
    Yang, Yuanhua
    Yang, Zhenwen
    Tian, Hongyan
    Li, Shengqing
    Shen, Jieyan
    Ji, Yingqun
    Zhang, Gangcheng
    Zhang, Caojin
    Wang, Guangyi
    Liu, Yuhao
    Cheng, Zhaozhong
    Yu, Zaixin
    Song, Zhiyuan
    Zheng, Zeqi
    Cui, Wei
    Chen, Yucheng
    Liu, Shuang
    Xiong, Changming
    Shan, Guangliang
    He, Jianguo
    RESPIROLOGY, 2021, 26 (02) : 196 - 203
  • [4] Balloon pulmonary angioplasty ameliorates long-term survival of patients with inoperable chronic thromboembolic pulmonary hypertension
    Tatebe, S.
    Sugimura, K.
    Aoki, T.
    Yamamoto, S.
    Yaoita, N.
    Sato, H.
    Konno, R.
    Satoh, K.
    Shimokawa, H.
    EUROPEAN HEART JOURNAL, 2017, 38 : 261 - 261
  • [5] Long-term bosentan in chronic thromboembolic pulmonary hypertension
    Seyfarth, Hans-Juergen
    Hammerschmidt, Stefan
    Pankau, Hans
    Winkler, Joerg
    Wirtz, Hubert
    RESPIRATION, 2007, 74 (03) : 287 - 292
  • [6] Development and Validation of a Nomogram for Balloon Pulmonary Angioplasty-Related Complications in Patients with Chronic Thromboembolic Pulmonary Hypertension
    Li, Xin
    Zhang, Yi
    Jin, Qi
    Luo, Qin
    Zhao, Qing
    Yang, Tao
    Zeng, Qixian
    Duan, Anqi
    Huang, Zhihua
    Hu, Meixi
    Zhang, Sicheng
    Gao, Luyang
    Xiong, Changming
    Zhao, Zhihui
    Liu, Zhihong
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2023, 24 (03)
  • [7] The long-term survival in patients with chronic thromboembolic pulmonary hypertension: experience from a single center in China
    Hu, Song
    Tan, Jiang-Shan
    Liu, Sheng
    Guo, Ting-Ting
    Song, Wu
    Peng, Fu-Hua
    Wu, Yan
    Gao, Xin
    Hua, Lu
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022, 53 (04) : 926 - 933
  • [8] The long-term survival in patients with chronic thromboembolic pulmonary hypertension: experience from a single center in China
    Song Hu
    Jiang-Shan Tan
    Sheng Liu
    Ting-Ting Guo
    Wu Song
    Fu-Hua Peng
    Yan Wu
    Xin Gao
    Lu Hua
    Journal of Thrombosis and Thrombolysis, 2022, 53 : 926 - 933
  • [9] THE LONG-TERM SURVIVAL IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: EXPERIENCE FROM A SINGLE CENTER IN CHINA
    Hu, S.
    Tan, J.
    Liu, S.
    Hua, L.
    CHEST, 2022, 161 (06) : 450A - 450A
  • [10] Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension
    Reichenberger, F.
    Voswinckel, R.
    Enke, B.
    Rutsch, M.
    El Fechtali, E.
    Schmehl, T.
    Oischewski, H.
    Schermuly, R.
    Weissmann, N.
    Ghofrani, H. A.
    Grimminger, F.
    Mayer, E.
    Seeger, W.
    EUROPEAN RESPIRATORY JOURNAL, 2007, 30 (05) : 922 - 927